C07D 263/54
Benzoxazoles
Official title: Benzoxazoles; Hydrogenated benzoxazoles
C07D263/54 (Benzoxazoles) appears on 1,584 US grants and 1,467 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,584
- Published applications
- 1,467
- Assignees
- 828
- Inventors
- 5,284
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 15 | 0 |
| 1977 | 27 | 0 |
| 1978 | 24 | 0 |
| 1979 | 13 | 0 |
| 1980 | 12 | 0 |
| 1981 | 18 | 0 |
| 1982 | 17 | 0 |
| 1983 | 14 | 0 |
| 1984 | 24 | 0 |
| 1985 | 22 | 0 |
| 1986 | 14 | 0 |
| 1987 | 24 | 0 |
| 1988 | 16 | 0 |
| 1989 | 25 | 0 |
| 1990 | 22 | 0 |
| 1991 | 19 | 0 |
| 1992 | 22 | 0 |
| 1993 | 27 | 0 |
| 1994 | 25 | 0 |
| 1995 | 26 | 0 |
| 1996 | 25 | 0 |
| 1997 | 17 | 0 |
| 1998 | 25 | 0 |
| 1999 | 23 | 0 |
| 2000 | 28 | 0 |
| 2001 | 39 | 9 |
| 2002 | 45 | 35 |
| 2003 | 31 | 58 |
| 2004 | 30 | 96 |
| 2005 | 31 | 72 |
| 2006 | 48 | 90 |
| 2007 | 41 | 73 |
| 2008 | 33 | 58 |
| 2009 | 49 | 75 |
| 2010 | 54 | 80 |
| 2011 | 46 | 71 |
| 2012 | 50 | 59 |
| 2013 | 59 | 46 |
| 2014 | 57 | 59 |
| 2015 | 54 | 66 |
| 2016 | 43 | 52 |
| 2017 | 53 | 57 |
| 2018 | 41 | 47 |
| 2019 | 49 | 52 |
| 2020 | 38 | 56 |
| 2021 | 27 | 44 |
| 2022 | 39 | 42 |
| 2023 | 28 | 63 |
| 2024 | 30 | 51 |
| 2025 | 27 | 34 |
| 2026 | 18 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Solid state form of tafamidis and a process for its preparation6 Oct 2026US 12,753,156 B2
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Organic light emitting element15 Sep 2026US 12,740,317 B2LG Display Co., Ltd.
- Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst8 Sep 2026US 12,729,169 B2The University of North Carolina at Chapel Hill
- Linear dipeptidyl peptidase 1 inhibitors and uses thereof24 Sep 2026US 2026/0285821 A1
- Organic electroluminescent material and device thereof24 Sep 2026US 2026/0293519 A1
- Fabk inhibitor compositions10 Sep 2026US 2026/0265242 A1The Texas A&M University System
- 3-alkylamine indole activators of serotonin receptors10 Sep 2026US 2026/0265250 A1
- Compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis3 Sep 2026US 2026/0258007 A1Septerna, Inc.
Most cited
By later US patents
- Benzo (b) thiophene carboxylate derivatives and pharmaceutical compositions182US 4,740,519 ACentre International de Recherches Dermatologiques (C.I.R.D.) · 1988
- Aryl piperazinyl-(C.sub.2 or C.sub.4) alkylene heterocyclic compounds having neuroleptic activity127US 4,831,031 APfizer Inc. · 1989
- Aryloxypropanolamine .beta. 3 adrenergic agonists115US 5,541,204 ABristol-Myers Squibb Company · 1996
- Enzymatic analysis using substrates that yield fluorescent precipitates114US 5,316,906 AMolecular Probes, Inc. · 1994
- Chemical compounds as inhibitors of amyloid beta protein production110US 5,624,937 AEli Lilly and Company · 1997